BNP Paribas Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $115M | Buy |
393,526
+133,393
| +51% | +$43.8M | 0.13% | 157 |
|
|
2025
Q4 | $91.2M | Buy |
260,133
+164,801
| +173% | +$55.7M | 0.1% | 189 |
|
|
2025
Q3 | $30.7M | Buy |
95,332
+21,560
| +29% | +$6.71M | 0.08% | 258 |
|
|
2025
Q2 | $28.7M | Sell |
73,772
-4,463
| -6% | -$1.8M | 0.07% | 274 |
|
|
2025
Q1 | $34M | Sell |
78,235
-24,399
| -24% | -$9.79M | 0.09% | 230 |
|
|
2024
Q4 | $37.9M | Sell |
102,634
-107,225
| -51% | -$44.9M | 0.09% | 226 |
|
|
2024
Q3 | $109M | Buy |
209,859
+9,916
| +5% | +$5.3M | 0.27% | 84 |
|
|
2024
Q2 | $108M | Buy |
199,943
+33,848
| +20% | +$17.9M | 0.28% | 78 |
|
|
2024
Q1 | $86.1M | Sell |
166,095
-164,154
| -50% | -$81.6M | 0.23% | 104 |
|
|
2023
Q4 | $156M | Buy |
330,249
+8,117
| +3% | +$3.75M | 0.43% | 46 |
|
|
2023
Q3 | $140M | Buy |
322,132
+140,305
| +77% | +$63.6M | 0.43% | 49 |
|
|
2023
Q2 | $80.8M | Buy |
181,827
+20,936
| +13% | +$9.66M | 0.25% | 99 |
|
|
2023
Q1 | $74M | Buy |
160,891
+12,477
| +8% | +$5.94M | 0.26% | 92 |
|
|
2022
Q4 | $76.1M | Buy |
148,414
+6,759
| +5% | +$3.43M | 0.27% | 92 |
|
|
2022
Q3 | $64.3M | Sell |
141,655
-4,538
| -3% | -$2.17M | 0.25% | 90 |
|
|
2022
Q2 | $70.5M | Buy |
146,193
+106,367
| +267% | +$52.6M | 0.27% | 90 |
|
|
2022
Q1 | $19.6M | Sell |
39,826
-27,647
| -41% | -$12.6M | 0.07% | 302 |
|
|
2021
Q4 | $31.3M | Buy |
67,473
+22,212
| +49% | +$9.34M | 0.1% | 240 |
|
|
2021
Q3 | $16.9M | Sell |
45,261
-5,268
| -10% | -$2M | 0.06% | 329 |
|
|
2021
Q2 | $19.3M | Sell |
50,529
-1,461
| -3% | -$558K | 0.07% | 323 |
|
|
2021
Q1 | $18.7M | Sell |
51,990
-12,776
| -20% | -$4.11M | 0.08% | 303 |
|
|
2020
Q4 | $20.8M | Sell |
64,766
-113,184
| -64% | -$34.7M | 0.1% | 245 |
|
|
2020
Q3 | $47.8M | Buy |
177,950
+146,708
| +470% | +$39.5M | 0.27% | 92 |
|
|
2020
Q2 | $8.22M | Sell |
31,242
-75,168
| -71% | -$20.1M | 0.06% | 335 |
|
|
2020
Q1 | $24.2M | Sell |
106,410
-3,103
| -3% | -$846K | 0.21% | 141 |
|
|
2019
Q4 | $33.1M | Buy |
109,513
+693
| +0.6% | +$191K | 0.23% | 130 |
|
|
2019
Q3 | $26.1M | Buy |
108,820
+34,426
| +46% | +$9.43M | 0.2% | 143 |
|
|
2019
Q2 | $21M | Sell |
74,394
-115
| -0.2% | -$31.4K | 0.17% | 166 |
|
|
2019
Q1 | $21.4M | Buy |
74,509
+44,608
| +149% | +$12.9M | 0.18% | 158 |
|
|
2018
Q4 | $7.75M | Buy |
29,901
+1,558
| +5% | +$428K | 0.07% | 333 |
|
|
2018
Q3 | $7.77M | Sell |
28,343
-21,213
| -43% | -$5.51M | 0.06% | 392 |
|
|
2018
Q2 | $11.8M | Sell |
49,556
-6,445
| -12% | -$1.49M | 0.1% | 296 |
|
|
2018
Q1 | $12.3M | Buy |
56,001
+23,115
| +70% | +$5.43M | 0.1% | 283 |
|
|
2017
Q4 | $7.4M | Buy |
32,886
+27,127
| +471% | +$5.78M | 0.06% | 402 |
|
|
2017
Q3 | $1.09M | Sell |
5,759
-1,327
| -19% | -$253K | 0.01% | 729 |
|
|
2017
Q2 | $1.33M | Sell |
7,086
-2,168
| -23% | -$390K | 0.01% | 709 |
|
|
2017
Q1 | $1.53M | Sell |
9,254
-2,721
| -23% | -$433K | 0.01% | 697 |
|
|
2016
Q4 | $1.72M | Sell |
11,975
-32,193
| -73% | -$4.31M | 0.02% | 678 |
|
|
2016
Q3 | $5.54M | Buy |
44,168
+244
| +0.6% | +$31.5K | 0.05% | 486 |
|
|
2016
Q2 | $5.77M | Sell |
43,924
-51,666
| -54% | -$7.07M | 0.05% | 458 |
|
|
2016
Q1 | $13.3M | Sell |
95,590
-3,233
| -3% | -$432K | 0.11% | 250 |
|
|
2015
Q4 | $13.8M | Buy |
98,823
+69
| +0.1% | +$9.51K | 0.12% | 233 |
|
|
2015
Q3 | $13.8M | Sell |
98,754
-23,597
| -19% | -$3.55M | 0.12% | 244 |
|
|
2015
Q2 | $20.1M | Sell |
122,351
-23,260
| -16% | -$3.72M | 0.16% | 176 |
|
|
2015
Q1 | $22.5M | Buy |
145,611
+12,626
| +9% | +$1.8M | 0.17% | 180 |
|
|
2014
Q4 | $16.7M | Sell |
132,985
-15,276
| -10% | -$1.89M | 0.13% | 202 |
|
|
2014
Q3 | $17.7M | Sell |
148,261
-24,264
| -14% | -$2.78M | 0.14% | 188 |
|
|
2014
Q2 | $18.6M | Buy |
172,525
+21,067
| +14% | +$2.17M | 0.14% | 190 |
|
|
2014
Q1 | $15.1M | Buy |
151,458
+51,857
| +52% | +$4.69M | 0.11% | 217 |
|
|
2013
Q4 | $9.2M | Sell |
99,601
-2,639
| -3% | -$234K | 0.07% | 305 |
|
|
2013
Q3 | $8.55M | Buy |
102,240
+3,598
| +4% | +$308K | 0.06% | 303 |
|
|
2013
Q2 | $8.07M | Buy |
+98,642
| New | +$7.38M | 0.06% | 330 |
|
Other funds holding ELV
VCM
VPM
BNP Paribas Asset Management's ELV Position: Q1 2026 in Review
BNP Paribas Asset Management increased its Elevance Health (ELV) stake by 51% in Q1 2026, buying an estimated $43.8M and bringing the position to 393,526 shares worth $115M. The position accounts for 0.13% of the portfolio, ranked #157.
BNP Paribas Asset Management first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $156M in Q4 2023. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- BNP Paribas Asset Management held 393,526 shares of Elevance Health worth $115M as of Q1 2026.
- BNP Paribas Asset Management bought 133,393 Elevance Health shares in Q1 2026, an estimated $43.8M.
- Elevance Health made up 0.13% of BNP Paribas Asset Management's portfolio in Q1 2026, its #157 holding.
- BNP Paribas Asset Management first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- BNP Paribas Asset Management's Elevance Health position peaked at $156M in Q4 2023.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.